In Vivo Accumulation of Regulatory T Cells Using Eliglustat‐Loaded Cryogels

Authors:

Abstract
Regulatory T cells (T regs ) maintain immune homeostasis and their adoptive transfer is being widely explored to mitigate inflammatory and autoimmune conditions. Here a biomaterial is developed to accumulate T regs at a specific anatomic location to bypass the need for ex vivo T reg isolation and adoptive transfer. It is first shown that eliglustat, an FDA‐approved inhibitor of UDP‐glucose ceramide glucosyltransferase, promotes T regs from both naïve and activated CD4 + T cells in vitro. Click‐crosslinked cryogels fabricated from alginate and collagen allow for a sustained release of CXCL10 or CXCL11, and when injected in subcutaneous tissues led to the enrichment of effector and memory T cells to the scaffolds. Loading eliglustat into these cryogels significantly enhances the local accumulation of T regs in vivo. These findings demonstrate that eliglustat‐loaded cryogels offer a simple yet effective biomaterial strategy to boost T reg directly in vivo, potentially providing a targeted method to treat various inflammatory and autoimmune diseases.
Funding Information
  • National Institutes of Health (R01 CA276459)
  • National Cancer Institute (K00 CA253759)

This publication has 44 references indexed in Scilit: